使用HepG2细胞揭示L-PGDS在肝脏胰岛素抵抗中的生物化学调节
Rhema Khairnar1, Md Asrarul Islam1, Kuljeet Singh1
1Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY,11439, USA.
Prostaglandins & other lipid mediators
|December 12, 2025
概括
与代谢功能障碍相关的脂肪性肝病 (MASLD) 涉及胰岛素耐药性和脂卡林前列腺素D2合成酶 (L-PGDS) 的下调. 这项研究发现L-PGDS水平由于细胞MASLD模型中转录和核转位减少而下降.
科学领域:
- 生物化学 生物化学
- 肝病学 肝病学是一种肝病学.
- 分子生物学分子生物学
背景情况:
- 与代谢功能障碍相关的脂肪性肝病 (MASLD) 是一个普遍存在的全球健康问题,与胰岛素耐药性密切相关.
- 卡林前列腺素D2合成酶 (L-PGDS) 缺乏与MASLD的发展和胰岛素抵抗有关.
- 在MASLD中L-PGDS的精确监管机制在很大程度上仍未被阐明.
研究的目的:
- 在MASLD的细胞模型中研究L-PGDS的生物化学调节.
- 探索胰岛素抵抗对L-PGDS表达和局部化的影响.
主要方法:
- 在使用棕酸盐和胰岛素联合治疗的HepG2细胞中建立了细胞MASLD模型.
- 评估了L-PGDS和前列腺素D2 (PGD2) 的水平.
- 研究了蛋白质体降解,自,转化活性和无处不在.
- 分析了基因和蛋白质表达,以及L-PGDS的亚细胞局部化.
主要成果:
- MASLD模型细胞显示了L-PGDS的显著下调,并降低了PGD2水平.
- 蛋白质体降解,自和转化途径并不是L-PGDS减少的原因.
- 观察到L-PGDS转录和蛋白质水平下降.
- 胰岛素抵抗诱导了L-PGDS从细胞质转移到细胞核的转移.
结论:
- 在MASLD中的L-PGDS下调似乎与转录调节和/或改变的亚细胞局部化有关.
- 需要进行进一步的研究,以充分定义在MASLD病变发生过程中控制L-PGDS调节的分子机制.
- 了解这些机制可能为MASLD提供新的治疗点.
相关概念视频
Hormones Regulating Blood Glucose
6.3K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
6.3K
Cell Specific Gene Expression
16.2K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.2K
Insulin: The Receptor and Signaling Pathways
2.6K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
2.6K


